SlideShare a Scribd company logo
1 of 14
40 CFR Part 158
Data Requirement Revisions


               Long Overdue Codification of Existing
                            Practice
                              OR
                 Way More Than We Bargained For




Karen E. Warkentien   Compliance Services International   1
Points for Discussion
    Financial Implications
       Registrants
       EPA
    Confidentiality Statements
       New Statements
       Release for Work Sharing
       Supplemental Claims
       Changes in Release of Information Procedures under
        FOIA
    Codifying “Nonexistent” Guidelines
       Guideline Series 835: Environmental Fate
       Guideline Series 850: Ecological Effects
    Comments Filed in Response to Proposed Rule

Karen E. Warkentien   Compliance Services International      2
Financial Implications
    Registrants
         Direct Study Costs
              EPA estimates that study costs will increase
               $50 million annually (approximately
               $420,000 per firm).
                     Need to look at EPA cost estimates to see if
                      they approximate “real-world” costs we
                      actually incur (see Appendix A of EPA Economic
                      Analysis document).
                     Need to look at EPA’s estimates on how often
                      such “new” data are required (see Appendix B
                      of EPA Economic Analysis document).


Karen E. Warkentien         Compliance Services International      3
Financial Implications
    Registrants (Continued)
         Study Monitoring Costs
              EPA’s Economic Analysis does not take
               these costs into account.
                     New requirements, like developmental
                      neurotoxicity and immunotoxicity testing, will
                      require substantial internal resources to
                      develop and monitor.
                     Existing requirements already account for
                      substantial expenses in study monitoring.



Karen E. Warkentien          Compliance Services International         4
Financial Implications
    EPA
         Appendix C of the Economic Analysis document
          attempts to quantify Agency and Contractor
          review time expenses.
            Total estimated costs are approximately $2
             million annually.
            Review times (in hours) may not be accurate
             (may be too low).
            Actual costs per hour may be inaccurate (based
             on a GS-13, step 5 salary).
         May impact on PRIA fees and review times.

Karen E. Warkentien   Compliance Services International   5
Confidentiality Claims
    EPA proposes to change the confidentiality
     statements currently outlined in PR Notice
     86-5.
         Still includes only two statements: one for
          confidentiality and one for no claims of
          confidentiality.
         Also includes an optional statement that can be
          added to allow EPA to release information to
          state and foreign governments for data sharing
          activities.
         Does not make any mention of supplemental
          claims of confidentiality (claims other than those
          under FIFRA §10(d)(1)(A), (B), or (C)).


Karen E. Warkentien   Compliance Services International    6
No Claim of Confidentiality
    No claim of confidentiality, on any basis
     whatsoever, is made for any information
     contained in this document. I acknowledge
     that information not designated as within
     the scope of FIFRA §10(d)(1)(A), (B), or
     (C) and which pertains to a registered or
     previously registered pesticide is not
     entitled to confidential treatment and may
     be released to the public, subject to the
     provisions regarding disclosure to
     multinational entities under FIFRA §10(g).

Karen E. Warkentien   Compliance Services International   7
Confidentiality Claim
    Information claimed as confidential
     has been removed to a confidential
     attachment.




Karen E. Warkentien   Compliance Services International   8
Optional Authorization to Release
Information
    I authorize the Environmental
     Protection Agency to release any
     information contained in this
     document to State or foreign
     governments, without relinquishing
     proprietary rights or any
     confidentiality claims asserted above.


Karen E. Warkentien   Compliance Services International   9
Changes in Release of Information
Under FOIA (40 CFR Part 2)
    Any information submitted on or after 4
     May 1988 that has not previously been
     claimed confidential under FIFRA §10(d)
     may be disclosed without further notice to
     the submitter.
    Any information deemed not entitled to
     confidential protection under FIFRA §10(b),
     40 CFR §158.33, and 40 CFR Part 2,
     Subpart B, may be released to the public
     without the Affirmation of Non-Multinational
     Status so long as it does not include the full
     methodology and complete test results.

Karen E. Warkentien   Compliance Services International   10
Codifying “Non-Existent”
Guidelines
    Guideline Series 835: Environmental Fate
         Guidelines issued in “Public Comment Draft”
          form in 1998.
         Only guidelines that have been made final are
          TSCA-specific.
         Guidelines proposed for codification in the
          proposed rule are not final and, technically, are
          not being used
            Still following old Pesticide Assessment
             Guidelines, Subdivision N, Guidance (series 160
             guidelines).

Karen E. Warkentien   Compliance Services International   11
Codifying “Non-Existent”
Guidelines
    Guideline Series 850: Terrestrial and
     Aquatic Nontarget Organisms
         Guidelines issued in “Public Comment
          Draft” form in 1998.
         Guidelines proposed for codification in
          the proposed rule are not final and,
          technically, are not being used
              Still following old Pesticide Assessment
               Guidelines, Subdivisions E and L, Guidance
               (series 70 and 140 guidelines).


Karen E. Warkentien    Compliance Services International   12
Comments Filed in Response to
Proposed Rule
    Comment on the proposed rule!!!
         Review the proposed rule and all the ancillary
          documents in the docket.
         These changes affect each and every registrant,
          large and small, in very real ways (financial,
          time, and human resources).
         This rule does much more than codify existing
          practice; it expands the scope greatly.
         New paradigms are in the works and it is
          counterproductive to put additional data
          requirements in place when they may fall out of
          favor in the near future (remember mesocosm
          studies????).
         Comment period closes on 9 June 2005.
Karen E. Warkentien   Compliance Services International   13
Where to Find Information
    EDOCKET
         Docket Control ID OPP-2004-0387
         http://docket.epa.gov




Karen E. Warkentien   Compliance Services International   14

More Related Content

What's hot

Online SAE reporting by CDSCO//Effective from 14/Mar/2021
Online SAE reporting by CDSCO//Effective from 14/Mar/2021 Online SAE reporting by CDSCO//Effective from 14/Mar/2021
Online SAE reporting by CDSCO//Effective from 14/Mar/2021 Anupam Bendre
 
Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...
Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...
Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...Marcellus Drilling News
 
EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...
EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...
EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...Marcellus Drilling News
 
EPA Oil and Natural Gas Emission Standards for New and Modified Sources
EPA Oil and Natural Gas Emission Standards for New and Modified SourcesEPA Oil and Natural Gas Emission Standards for New and Modified Sources
EPA Oil and Natural Gas Emission Standards for New and Modified SourcesMarcellus Drilling News
 
Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...
Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...
Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...Marcellus Drilling News
 
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016Pistoia Alliance
 
FDA Plans to Restart Inspections: Update
FDA Plans to Restart Inspections: UpdateFDA Plans to Restart Inspections: Update
FDA Plans to Restart Inspections: UpdateEMMAIntl
 
Pfizer Quarterly Corporate Performance - Fourth Quarter 2007
Pfizer Quarterly Corporate Performance - Fourth Quarter 2007Pfizer Quarterly Corporate Performance - Fourth Quarter 2007
Pfizer Quarterly Corporate Performance - Fourth Quarter 2007finance5
 
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...Epstein Becker Green
 
FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011
FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011
FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011Michael Swit
 
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...Epstein Becker Green
 

What's hot (11)

Online SAE reporting by CDSCO//Effective from 14/Mar/2021
Online SAE reporting by CDSCO//Effective from 14/Mar/2021 Online SAE reporting by CDSCO//Effective from 14/Mar/2021
Online SAE reporting by CDSCO//Effective from 14/Mar/2021
 
Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...
Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...
Hydraulic Fracturing Chemicals and Mixtures; Advance Notice of Proposed Rulem...
 
EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...
EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...
EPA: Petroleum Refinery Sector Risk and Technology Review and New Source Perf...
 
EPA Oil and Natural Gas Emission Standards for New and Modified Sources
EPA Oil and Natural Gas Emission Standards for New and Modified SourcesEPA Oil and Natural Gas Emission Standards for New and Modified Sources
EPA Oil and Natural Gas Emission Standards for New and Modified Sources
 
Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...
Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...
Report: Enhanced EPA Oversight and Action Can Further Protect Water Resources...
 
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
 
FDA Plans to Restart Inspections: Update
FDA Plans to Restart Inspections: UpdateFDA Plans to Restart Inspections: Update
FDA Plans to Restart Inspections: Update
 
Pfizer Quarterly Corporate Performance - Fourth Quarter 2007
Pfizer Quarterly Corporate Performance - Fourth Quarter 2007Pfizer Quarterly Corporate Performance - Fourth Quarter 2007
Pfizer Quarterly Corporate Performance - Fourth Quarter 2007
 
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...
 
FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011
FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011
FDA Warning Letters -- A Focus on Clinical Quality -- 2010 and 2011
 
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...
 

Similar to 20050503 40 Cfr Part 158 Proposed Rule Presentation

EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...
EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...
EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...Marcellus Drilling News
 
The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...
The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...
The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...Michael Swit
 
EPA "No Wastewater Treatment in Sewage Plants" Rule
EPA "No Wastewater Treatment in Sewage Plants" RuleEPA "No Wastewater Treatment in Sewage Plants" Rule
EPA "No Wastewater Treatment in Sewage Plants" RuleMarcellus Drilling News
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxSusmithaTella2
 
FDA Draft 510(K) Guidance July 27, 2011
FDA Draft 510(K) Guidance July 27, 2011FDA Draft 510(K) Guidance July 27, 2011
FDA Draft 510(K) Guidance July 27, 2011crr99999
 
FDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot ProgramsFDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot ProgramsEMMAIntl
 
EPA New Rules Governing Air Pollution Standards for Hydraulic Fracturing
EPA New Rules Governing Air Pollution Standards for Hydraulic FracturingEPA New Rules Governing Air Pollution Standards for Hydraulic Fracturing
EPA New Rules Governing Air Pollution Standards for Hydraulic FracturingMarcellus Drilling News
 
Guidance for industry and food and
Guidance for industry and food andGuidance for industry and food and
Guidance for industry and food andHumoor Hum
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The MarkeTech Group
 
Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...
Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...
Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...Marcellus Drilling News
 
Mike Winegar Medpace Medical Device
Mike Winegar Medpace Medical DeviceMike Winegar Medpace Medical Device
Mike Winegar Medpace Medical DeviceMedpace
 
Navigating the California Right to Know Designated Lists & NY DEC Updates
Navigating the California Right to Know Designated Lists & NY DEC UpdatesNavigating the California Right to Know Designated Lists & NY DEC Updates
Navigating the California Right to Know Designated Lists & NY DEC UpdatesDell Tech
 
Know about the fda 510 k submission
Know about the fda 510 k submissionKnow about the fda 510 k submission
Know about the fda 510 k submissionshane99
 
December 2011 Newsletter
December 2011 NewsletterDecember 2011 Newsletter
December 2011 Newsletterkhorton123
 
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsDisaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsPerficient, Inc.
 
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...Market iT
 
ISO 14001 Tip #6 - How to Meet Compliance Obligations?
ISO 14001 Tip #6 - How to Meet Compliance Obligations?ISO 14001 Tip #6 - How to Meet Compliance Obligations?
ISO 14001 Tip #6 - How to Meet Compliance Obligations?Aury Hathout
 

Similar to 20050503 40 Cfr Part 158 Proposed Rule Presentation (20)

EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...
EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...
EPA's Final Rule Forcing O&G Drillers to Capture Tiny Amounts of Fugitive Met...
 
The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...
The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...
The Medical Device User Fee and Modernization Act of 2002 -- “MDUFMA” Overvie...
 
EPA "No Wastewater Treatment in Sewage Plants" Rule
EPA "No Wastewater Treatment in Sewage Plants" RuleEPA "No Wastewater Treatment in Sewage Plants" Rule
EPA "No Wastewater Treatment in Sewage Plants" Rule
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
 
FDA Draft 510(K) Guidance July 27, 2011
FDA Draft 510(K) Guidance July 27, 2011FDA Draft 510(K) Guidance July 27, 2011
FDA Draft 510(K) Guidance July 27, 2011
 
FDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot ProgramsFDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot Programs
 
EPA New Rules Governing Air Pollution Standards for Hydraulic Fracturing
EPA New Rules Governing Air Pollution Standards for Hydraulic FracturingEPA New Rules Governing Air Pollution Standards for Hydraulic Fracturing
EPA New Rules Governing Air Pollution Standards for Hydraulic Fracturing
 
Guidance for industry and food and
Guidance for industry and food andGuidance for industry and food and
Guidance for industry and food and
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011
 
Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...
Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...
Federal Register - Oct 22, 2015 - EPA 40 CFR Part 98 - Greenhouse Gas Reporti...
 
Mike Winegar Medpace Medical Device
Mike Winegar Medpace Medical DeviceMike Winegar Medpace Medical Device
Mike Winegar Medpace Medical Device
 
Navigating the California Right to Know Designated Lists & NY DEC Updates
Navigating the California Right to Know Designated Lists & NY DEC UpdatesNavigating the California Right to Know Designated Lists & NY DEC Updates
Navigating the California Right to Know Designated Lists & NY DEC Updates
 
Know about the fda 510 k submission
Know about the fda 510 k submissionKnow about the fda 510 k submission
Know about the fda 510 k submission
 
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
 
December 2011 Newsletter
December 2011 NewsletterDecember 2011 Newsletter
December 2011 Newsletter
 
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsDisaster Recovery and Business Continuity for Your Clinical and Safety Systems
Disaster Recovery and Business Continuity for Your Clinical and Safety Systems
 
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
 
Ucm072331
Ucm072331Ucm072331
Ucm072331
 
Ucm072331
Ucm072331Ucm072331
Ucm072331
 
ISO 14001 Tip #6 - How to Meet Compliance Obligations?
ISO 14001 Tip #6 - How to Meet Compliance Obligations?ISO 14001 Tip #6 - How to Meet Compliance Obligations?
ISO 14001 Tip #6 - How to Meet Compliance Obligations?
 

20050503 40 Cfr Part 158 Proposed Rule Presentation

  • 1. 40 CFR Part 158 Data Requirement Revisions Long Overdue Codification of Existing Practice OR Way More Than We Bargained For Karen E. Warkentien Compliance Services International 1
  • 2. Points for Discussion  Financial Implications  Registrants  EPA  Confidentiality Statements  New Statements  Release for Work Sharing  Supplemental Claims  Changes in Release of Information Procedures under FOIA  Codifying “Nonexistent” Guidelines  Guideline Series 835: Environmental Fate  Guideline Series 850: Ecological Effects  Comments Filed in Response to Proposed Rule Karen E. Warkentien Compliance Services International 2
  • 3. Financial Implications  Registrants  Direct Study Costs  EPA estimates that study costs will increase $50 million annually (approximately $420,000 per firm).  Need to look at EPA cost estimates to see if they approximate “real-world” costs we actually incur (see Appendix A of EPA Economic Analysis document).  Need to look at EPA’s estimates on how often such “new” data are required (see Appendix B of EPA Economic Analysis document). Karen E. Warkentien Compliance Services International 3
  • 4. Financial Implications  Registrants (Continued)  Study Monitoring Costs  EPA’s Economic Analysis does not take these costs into account.  New requirements, like developmental neurotoxicity and immunotoxicity testing, will require substantial internal resources to develop and monitor.  Existing requirements already account for substantial expenses in study monitoring. Karen E. Warkentien Compliance Services International 4
  • 5. Financial Implications  EPA  Appendix C of the Economic Analysis document attempts to quantify Agency and Contractor review time expenses.  Total estimated costs are approximately $2 million annually.  Review times (in hours) may not be accurate (may be too low).  Actual costs per hour may be inaccurate (based on a GS-13, step 5 salary).  May impact on PRIA fees and review times. Karen E. Warkentien Compliance Services International 5
  • 6. Confidentiality Claims  EPA proposes to change the confidentiality statements currently outlined in PR Notice 86-5.  Still includes only two statements: one for confidentiality and one for no claims of confidentiality.  Also includes an optional statement that can be added to allow EPA to release information to state and foreign governments for data sharing activities.  Does not make any mention of supplemental claims of confidentiality (claims other than those under FIFRA §10(d)(1)(A), (B), or (C)). Karen E. Warkentien Compliance Services International 6
  • 7. No Claim of Confidentiality  No claim of confidentiality, on any basis whatsoever, is made for any information contained in this document. I acknowledge that information not designated as within the scope of FIFRA §10(d)(1)(A), (B), or (C) and which pertains to a registered or previously registered pesticide is not entitled to confidential treatment and may be released to the public, subject to the provisions regarding disclosure to multinational entities under FIFRA §10(g). Karen E. Warkentien Compliance Services International 7
  • 8. Confidentiality Claim  Information claimed as confidential has been removed to a confidential attachment. Karen E. Warkentien Compliance Services International 8
  • 9. Optional Authorization to Release Information  I authorize the Environmental Protection Agency to release any information contained in this document to State or foreign governments, without relinquishing proprietary rights or any confidentiality claims asserted above. Karen E. Warkentien Compliance Services International 9
  • 10. Changes in Release of Information Under FOIA (40 CFR Part 2)  Any information submitted on or after 4 May 1988 that has not previously been claimed confidential under FIFRA §10(d) may be disclosed without further notice to the submitter.  Any information deemed not entitled to confidential protection under FIFRA §10(b), 40 CFR §158.33, and 40 CFR Part 2, Subpart B, may be released to the public without the Affirmation of Non-Multinational Status so long as it does not include the full methodology and complete test results. Karen E. Warkentien Compliance Services International 10
  • 11. Codifying “Non-Existent” Guidelines  Guideline Series 835: Environmental Fate  Guidelines issued in “Public Comment Draft” form in 1998.  Only guidelines that have been made final are TSCA-specific.  Guidelines proposed for codification in the proposed rule are not final and, technically, are not being used  Still following old Pesticide Assessment Guidelines, Subdivision N, Guidance (series 160 guidelines). Karen E. Warkentien Compliance Services International 11
  • 12. Codifying “Non-Existent” Guidelines  Guideline Series 850: Terrestrial and Aquatic Nontarget Organisms  Guidelines issued in “Public Comment Draft” form in 1998.  Guidelines proposed for codification in the proposed rule are not final and, technically, are not being used  Still following old Pesticide Assessment Guidelines, Subdivisions E and L, Guidance (series 70 and 140 guidelines). Karen E. Warkentien Compliance Services International 12
  • 13. Comments Filed in Response to Proposed Rule  Comment on the proposed rule!!!  Review the proposed rule and all the ancillary documents in the docket.  These changes affect each and every registrant, large and small, in very real ways (financial, time, and human resources).  This rule does much more than codify existing practice; it expands the scope greatly.  New paradigms are in the works and it is counterproductive to put additional data requirements in place when they may fall out of favor in the near future (remember mesocosm studies????).  Comment period closes on 9 June 2005. Karen E. Warkentien Compliance Services International 13
  • 14. Where to Find Information  EDOCKET  Docket Control ID OPP-2004-0387  http://docket.epa.gov Karen E. Warkentien Compliance Services International 14